Compounds specific to adenosine a1 and a3 receptors and uses thereof

   
   

This invention pertains to compounds which specifically inhibit the adenosine A.sub.1 and A.sub.3 receptors and the use of these compounds to treat a disease associated with A3 adenosine receptor in a subject, comprising administering to the subject a therapeutically effective amount of the compounds.

 
Web www.patentalert.com

< 5-HT receptor ligands and uses thereof

< Ethylene diamine derivatives and their use as orexin-receptor antagonists

> Protein tyrosine phosphatase 1B (PTP-1B) inhibitors and methods of using the same

> 1-Alkyl-4-(3-substitutedphenyl)piperidines

~ 00177